Consensus Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-04-19 pm EDT			5-day change	1st Jan Change
147.9 ^USD	+1.49%		+0.26%	-5.63%

Apr. 19	WHO Likely to Issue Wider Warning About J&J Cough Syrup Contamination, Reuters Reports	DJ
Apr. 19	WHO says wider alert on contaminated J&J cough syrup 'likely'	RE

Evolution of the average Target Price on Johnson & Johnson

Price target over the last 5 years

History of analyst recommendation changes

51ab07f2c537b9479d114902a38df1.ndBKF8EKDjh2Jkkj4xtwf9Rur4LkuCZxU2gJCuaup3A.5JsOR6U4Ql1PfzpxzmhFBZM-xenc-nMQESQ8UpaZ0BH55gJO9D5nDEJ2Og~090a4526f70aa8871af053e056833d4a

Analyst Recommendations on Johnson & Johnson

HSBC Upgrades Johnson & Johnson to Buy From Hold, Raises Price Target to $170 From $169	Apr. 18	MT
DZ Bank Adjusts Johnson & Johnson's Price Target to $176 From $181, Maintains Buy Rating	Apr. 18	MT
Bernstein Adjusts Johnson & Johnson's Price Target to $161 From $172, Maintains Market Perform Rating	Apr. 18	MT
BofA Securities Adjusts Price Target on Johnson & Johnson to $170 From $180, Maintains Neutral Rating	Apr. 17	MT
Morgan Stanley Adjusts Johnson & Johnson's Price Target to $167 From $168, Keeps Equalweight Rating	Apr. 17	MT
RBC Adjusts Johnson & Johnson's Price Target to $175 From $181, Keeps Outperform Rating	Apr. 17	MT
Raymond James Adjusts Johnson & Johnson's Price Target to $170 From $175, Maintains Outperform Rating	Apr. 17	MT
Stifel Cuts Johnson & Johnson's Price Target to $155 From $160	Apr. 16	MT
Morgan Stanley Trims Price Target on Johnson & Johnson to $168 From $169, Keeps Equalweight Rating	Apr. 09	MT
Johnson & Johnson Recommends Shareholders to Reject TRC Capital Investment's Mini-Tender Offer	Apr. 05	MT
J&J recommends shareholders to reject 'mini-tender' offer by TRC Capital Investment	Apr. 04	RE
Guggenheim Trims Price Target on Johnson & Johnson to $167 From $169, Maintains Neutral Rating	Jan. 24	MT
Morgan Stanley Adjusts Price Target on Johnson & Johnson to $169 From $170, Maintains Equalweight Rating	Jan. 24	MT
The market awaits the BCE meeting and earnings reports	Jan. 23
The start of a new bull market?	Jan. 22
B. Riley Downgrades Ambrx Biopharma to Neutral From Buy on Heels of Announced Sale to Johnson & Johnson, Adjusts PT to $28 From $26	Jan. 09	MT
Raymond James Raises Johnson & Johnson's Price Target to $175 From $172, Maintains Outperform Rating	Jan. 03	MT
ANALYST RECOMMENDATIONS : Adobe, Airbnb, Netflix, Nike, Etsy...	Dec. 14
Wells Fargo Downgrades Johnson & Johnson to Equalweight From Overweight, Cuts Price Target to $163 From $170	Dec. 13	MT
Morgan Stanley Trims Price Target on Johnson & Johnson to $170 From $171, Keeps Equalweight Rating	Dec. 12	MT
Job losses delight investors	Dec. 06
RBC Raises Price Target on Johnson & Johnson to $181 From $178, 'Encouraged' by Enterprise Business Review, Keeps Outperform Rating	Dec. 06	MT
UBS Upgrades Johnson & Johnson to Buy From Neutral, Raises Price Target to $180 From $167	Dec. 01	MT
J&J : Wells Fargo remains positive, lowers target	Nov. 28	CF
EMEA Morning Briefing: Cooling U.S. Inflation Fuels Hopes That Rates Have Peaked	Nov. 15	DJ

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

145.7 USD

Average target price

172.5 USD

Spread / Average Target

+18.38%

High Price Target

215 USD

Spread / Highest target

+47.52%

Low Price Target

155 USD

Spread / Lowest Target

+6.35%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Johnson & Johnson

HSBC
DZ Bank
Bernstein
BofA Securities
Morgan Stanley
RBC Capital Markets
Raymond James
Stifel Nicolaus
Guggenheim
Wells Fargo Securities
UBS
Atlantic Equities
Barclays
JPMorgan Chase
Credit Suisse
SVB Securities LLC
Citigroup
Goldman Sachs
DA Davidson
SVB Financial
Daiwa Securities
Sanford Bernstein
Cantor Fitzgerald
J.P. Morgan Chase
Cowen
SVB Leerink
RBC	Brandon Henry

Ratings for Johnson & Johnson

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar